BCL6 and acute lymphoblastic leukemia: Both chemical inhibition and more specific shRNA knockdown of BCL6 in ALL cells reduced cyclin D3 levels with BCL6 overexpression correlated with increased cyclin D3 protein abundance (Figure 3).